Cardiomyopathies Epidemiology Analysis and Forecast, 2021-2031
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
In the 7MM, the diagnosed prevalent cases of cardiomyopathies was 2,268,240 cases in 2021. The market is expected to grow at an AGR of more than 2% during the forecast period. Cardiomyopathy is a general term for a collection of diverse conditions of the heart muscle that inhibit the heart muscle’s ability to pump blood. The main forms of cardiomyopathy are dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARCM), which combined are referred to as cardiomyopathies in this report.
What are the key subtypes in the Cardiomyopathies market?
The key subtypes in the Cardiomyopathies market are DCM, HCM, RCM, and ARCM. In 2021, DCM and HCM were the most common cardiomyopathy subtypes in the 7MM.
Cardiomyopathies market, by subtypes
For more subtype insights, download a free report sample
Diagnosed Prevalent Cases of Cardiomyopathies by Etiology
The two segments in the diagnosed prevalent cases of cardiomyopathies by etiology are acquired and familial. The most diagnosed cases of cardiomyopathies in the 7MM were acquired in 2021. This trend is attributed to two factors. The first is largely due to the large number of cases in the US. The second is due to the large number of diagnosed DCM cases in the US, France, Italy, and the UK, where the proportion of acquired cases is higher than in other cardiomyopathy subtypes.
Cardiomyopathies market, by etiology
For more etiology insights, download a free report sample
Diagnosed Prevalent Cases of Dilated Cardiomyopathy with Ischemia
The two key segments in the diagnosed prevalent cases of cardiomyopathies by ischemia are Ischemic and non-ischemic. In 2021, most diagnosed DCM cases in the 7MM were non-ischemic. This proportion was similar across most markets, except for Germany, Italy, and Japan.
Cardiomyopathies market, by Ischemia
For more ischemia insights, download a free report sample
Market report overview
Market size 2021 | 2,268,240 cases |
AGR% | >2% |
Forecast period | 2021-2031 |
Key subtype | DCM, HCM, RCM, and ARCM |
Key prevalent cases of cardiomyopathies by etiology | Acquired and Familial |
Key diagnosed prevalent cases of cardiomyopathies by ischemia | Ischemic and Non-Ischemic |
Scope
- The cardiomyopathies epidemiology report and model provide an overview of the risk factors, comorbidities, and global and historical trends for cardiomyopathies (DCM, HCM, RCM, and ARCM) in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan).
- The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of cardiomyopathies segmented by subtype, sex, and age (under 18 years, 18–29 years, and by 10-year age groups for ages 30 years up to 80 years and older) in these markets. The diagnosed prevalent cases are further segmented by causes (acquired versus inherited) and ischemic cases (DCM only).
- The epidemiology model corresponding to this report provides additional clinically relevant segmentations for the diagnosed prevalent cases of cardiomyopathies including subtype specific etiology
- The cardiomyopathies epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in cardiomyopathies.
- The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The Cardiomyopathies Epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global cardiomyopathies markets.
- Quantify patient populations in the global cardiomyopathies markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for cardiomyopathies therapeutics in each of the markets covered.
- Understand magnitude of the population with cardiomyopathies by age, sex, etiology, and ischemia (DCM only).
Table of Contents
Table
Figures
Frequently asked questions
-
What was the diagnosed prevalent cases of cardiomyopathies in the 7MM in 2021?
In the 7MM, the diagnosed prevalent cases of cardiomyopathies was 2,268,240 cases in 2021.
-
What is the cardiomyopathies market growth rate in the year 2021?
The number of prevalent cases of cardiomyopathies is expected to grow at an AGR of more than 2% during the forecast period.
-
What are the key subtypes in the cardiomyopathies market?
The key subtypes in the cardiomyopathies market are DCM, HCM, RCM, and ARCM.
-
What are the key segments in etiology in the cardiomyopathies market?
The key segments in etiology in the cardiomyopathies market are acquired and familial.
-
What are the key segments of Ischemia in the cardiomyopathies market?
The key segments of Ischemia in the cardiomyopathies market are ischemic and non-ischemic.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.